Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages by Social Determinants of Health

被引:5
|
作者
Zhu, Ruixin [1 ]
Wang, Ran [1 ]
He, Jingjing [1 ]
Wang, Langrun [1 ]
Chen, Huiyu [1 ]
Niu, Xiaokang [1 ]
Sun, You [2 ]
Guan, Yiran [1 ]
Gong, Yifan [1 ]
Zhang, Liwei [1 ]
An, Peng [1 ]
Li, Keji [3 ]
Ren, Fazheng [1 ]
Xu, Weili [4 ]
Guo, Jie [1 ,4 ]
机构
[1] China Agr Univ, Dept Nutr & Hlth, Key Lab Precis Nutr & Food Qual, 10 Tianxiu Rd, Beijing, Peoples R China
[2] Tianjin Univ Sci & Technol, Coll Food Sci & Engn, Tianjin, Peoples R China
[3] Peking Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing, Peoples R China
[4] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Solna, Sweden
基金
中国博士后科学基金;
关键词
US ADULTS; NHANES;
D O I
10.1001/jamanetworkopen.2024.45309
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance Cardiovascular-kidney-metabolic (CKM) syndrome-a novel, multistage, multisystem disorder as defined by the American Heart Association-is highly prevalent in the US. However, the prevalence of CKM stages by social determinants of health (SDOH) remains unclear. Objective To investigate whether the prevalence of CKM stages varies by SDOH in US adults. Design, Setting, and Participants This cross-sectional study used data from the National Health and Nutrition Examination Survey (1999-2018) and included a nationally representative sample of adults aged 30 to 79 years through complex, multistage probability sampling. Data were analyzed from April 1 to June 15, 2024. Exposures The exposures included 5 CKM stages (ie, stages 0-4) reflecting progressive pathophysiology, with advanced (stages 3 or 4) and nonadvanced (stages 0, 1, or 2) disease. CKM stages were defined based on risk factors for metabolic syndrome, cardiovascular disease, and chronic kidney disease. Main Outcome and Measures The main outcome was the age-standardized prevalence of CKM stages and advanced CKM stages across SDOH, including education, marital status, family income, food security, health insurance, employment, home ownership, and health care access. Results Among 29 722 participants (weighted mean [SE] age, 50.8 [0.1] years; weighted 50.7% male), the age-standardized prevalence of CKM stages 0 to 4 was 13.6% (95% CI, 13.0%-14.3%), 29.9% (95% CI, 29.1%-30.7%), 43.7% (95% CI, 42.9%-44.5%), 4.7% (95% CI, 4.4%-5.0%), and 8.1% (95% CI, 7.6%-8.5%), respectively. Significant differences were observed in the prevalence of CKM stages across all unfavorable SDOH of interest compared with their favorable counterparts, with unemployment (18.8% [95% CI, 17.7%-20.1%] vs 11.4% [95% CI, 11.0%-11.9%]), low family income (16.1% [95% CI, 15.4%-16.8%] vs 10.1% [95% CI, 9.5%-10.7%]), and food insecurity (18.3% [95% CI, 17.1%-19.6%] vs 11.7% [95% CI, 11.2%-12.2%]) associated with an increased likelihood of advanced CKM stages. Participants with 2 or more unfavorable SDOH were more likely to have advanced CKM stages (age-standardized prevalence, 15.8% [95% CI, 15.2%-16.5%] vs 10.5% [95% CI, 9.9%-11.1%] with <2 unfavorable SDOH). Living in a rented home (15.9% [95% CI, 14.7%-17.0%] vs 9.3% [95% CI, 8.7%-9.9%] owning the home) or not living with a partner (13.2% [95% CI, 12.3%-14.3%] vs 9.2% [95% CI, 8.5%-9.8%] living with a partner) increased the likelihood of advanced CKM stages in female but not male participants. Conclusions and Relevance In this cross-sectional study, disparities in the prevalence of CKM stages by SDOH, particularly family income, food security, and employment, with notable sex differences, were observed in US adults. These findings highlight the need to address inequities in CKM syndrome through targeted interventions.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Associations of cardiovascular-kidney-metabolic syndrome stages with premature mortality and the role of social determinants of health
    Zhu, Ruixin
    Wang, Ran
    He, Jingjing
    Wang, Langrun
    Chen, Huiyu
    Wang, Yifan
    An, Peng
    Li, Keji
    Ren, Fazheng
    Xu, Weili
    Martinez, J. Alfredo
    Raben, Anne
    Guo, Jie
    JOURNAL OF NUTRITION HEALTH & AGING, 2025, 29 (04):
  • [2] Integrating Social Determinants of Health in the Management of Cardiovascular-Kidney-Metabolic Syndrome
    April-Sanders, Ayana K.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (16):
  • [3] Social Determinants of Health for Cardiovascular-Kidney-Metabolic Syndrome Among Patients With Diabetes
    Belay, Kibret Enyew
    Feleke, Yeweyenhareg
    Alemneh, Theodros Aberra
    Haile, Asteway Mulat
    Abebe, Dawit Girma
    JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 9 (01)
  • [4] HIGH PREVALENCE OF THE CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME
    Tian, Zhejia
    Schmidt-ott, Kai
    Melk, Anette
    Schmidt, Bernhard
    JOURNAL OF HYPERTENSION, 2024, 42
  • [5] Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020
    Aggarwal, Rahul
    Ostrominski, John W.
    Vaduganathan, Muthiah
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (21): : 1858 - 1860
  • [6] An Overview of Cardiovascular-Kidney-Metabolic Syndrome
    Ferdinand, Keith C.
    AMERICAN JOURNAL OF MANAGED CARE, 2024, 30 (10): : S181 - S188
  • [7] Social Risk Profile and Cardiovascular-Kidney-Metabolic Syndrome in US Adults
    Li, Jingkuo
    Lei, Lubi
    Wang, Wei
    Ding, Wenbo
    Yu, Yanwu
    Pu, Boxuan
    Peng, Yue
    Li, Yinchu
    Zhang, Lihua
    Guo, Yuanlin
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (16):
  • [8] Cardiovascular-kidney-metabolic syndrome - An integrative review
    Kittelson, Katiana Simoes
    Gasparotto, Arquimedes
    Fillmore, Natasha
    Gomes, Roberto da Silva
    PROGRESS IN CARDIOVASCULAR DISEASES, 2024, 87 : 26 - 36
  • [9] A united vision for cardiovascular-kidney-metabolic health
    Quaggin, Susan E.
    Magod, Benjamin
    NATURE REVIEWS NEPHROLOGY, 2024, 20 (05) : 273 - 274
  • [10] Prevalence, Incidence, and Progression of Cardiovascular-Kidney-Metabolic Syndrome in a Diverse Nationwide Cohort
    Tan, Savannah Xinyi
    Li, Fan
    Mac Grory, Brian
    Lusk, Jay
    CIRCULATION, 2024, 150